Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase 3 HERO Trial Finds Relugolix to Be Superior to Leuprolide in Prostate Cancer.AuthorsSlater, HannahSubjectsLUTEINIZING hormone releasing hormone antagonists; CELL receptors; CLINICAL trials; CONVALESCENCE; PROSTATE tumors; TREATMENT effectiveness; ADVERSE health care events; LEUPROLIDEPublicationOncology (08909091), 2020, Vol 34, Issue 7, p252ISSN0890-9091Publication typeArticle